Product code NJO— Microbiology

SHERLOCK MYCOBACTERIA IDENTIFICATION SYSTEM

Classification name
System, Mycolic Acid Analysis, Mycobacterium Tuberculosis
Device class
Class 1
Regulation
21 CFR 866.3370
Advisory panel
Microbiology
Total cleared
1
First cleared
Most recent

FDA classification definition

“A mycolic acids analysis system is intended to aid in the identification of M. tuberculosis and differentiation from other mycobacteria species through the analysis of mycolic acids derived from cultured bacterial samples, using high performance liquid chromatography (HPLC) performed and pattern recognition software. The system is used, along with other identification methods, to identify mycobacteria that have been isolated from clinical specimens by traditional culturing techniques. Following observation of growth on the solid medium, identification of the mycobacterial isolate is done with extraction and analysis of mycolic acids. Results should be interpreted in conjunction with other laboratory observations and procedures.”

— U.S. Food and Drug Administration, device classification record for product code NJO under 21 CFR 866.3370, via openFDA

Market context for product code NJO

FDA has cleared 1 device under product code NJO, all in 2002, filed by 1 applicant company. No FDA device recalls reference this product code. Class I devices are low-risk and subject to FDA general controls; many Class I device types are exempt from 510(k) premarket notification.

Top applicants under product code NJO

Recent clearances under product code NJO

Data sourced from openFDA. This site is unofficial and independent of the FDA.